An MPV of 8.9 fL is completely normal and requires no further evaluation
An MPV of 8.9 fL falls squarely within the normal reference range and, in the absence of other abnormalities or bleeding symptoms, requires no action.
Normal Reference Range
The most definitive epidemiologic study of healthy adults established that 95% of normal individuals have an MPV between 7.2 and 11.7 fL, with a mean of 8.9 ± 1.4 fL 1. Your value of 8.9 fL is literally the population mean. Historical data confirms this range, with normal adults showing MPV values from 7.0 to 10.5 fL 2.
When to Investigate Further
According to ISTH guidelines for inherited platelet function disorders, laboratory investigation for platelet abnormalities should only be pursued when 3:
- Clinical bleeding history is present: unexplained bruising, epistaxis, menorrhagia, bleeding with procedures/dental extractions
- Elevated bleeding assessment tool (BAT) score suggests abnormal bleeding tendency
- Physical examination reveals syndromic features (hearing loss, cardiac/facial dysmorphisms, skin discoloration)
- Blood smear shows altered platelet size or structure
The guideline explicitly states that first-line screening tests (blood smear, platelet aggregometry, granule release assays, flow cytometry) should only follow if preliminary investigations are normal but clinical suspicion remains high 3.
Common Pitfalls to Avoid
- Do not over-interpret normal values: An MPV of 8.9 fL with an otherwise normal CBC has no pathological significance
- Do not order reflexive platelet function testing: This wastes resources and may generate false-positive results requiring unnecessary follow-up
- Recognize pre-analytical variability: MPV can vary with anticoagulant type and time to analysis 4, but this is irrelevant when values are clearly normal
Clinical Context
While elevated MPV (>11.7 fL) may warrant evaluation for cardiovascular risk or thrombophilia in specific clinical contexts 1, 5, a normal MPV of 8.9 fL has no predictive or diagnostic value and should not trigger further testing.